Alison K. Conlin, MD

Accepting New Patients
4805 Northeast Glisan Street, Suite 11N-1
Portland, OR 97213
2320.8 miles away
Speaks: English

Providence Cancer Institute Franz Clinic

4805 Northeast Glisan Street, Suite 11N-1, Portland, OR 97213

Are you covered?

Check to see if your insurance is covered by this provider.

About Alison K. Conlin

"We aim to care for our patients with the utmost respect and compassion while offering the most advanced treatments and options to participate in new and exciting clinical trials. Our focus is always on the patient and helping them and their family members feel the complete care they are receiving." - Alison Conlin, M.D.

Dr. Conlin's interests are in both early and advanced stage breast cancer and the development and incorporation of new drugs for these patients. She sees patients in Portland, OR.


Memorial Sloan-Kettering Cancer Center


Weill Cornell Medical Center

Medical School

State University of New York Upstate Medical University


Weill Cornell Medical Center


Board Certifications
  • American Board of Internal Medicine, Medical Oncology
Providence Cancer Institute Franz Clinic
4805 Northeast Glisan Street, Suite 11N-1
Portland, OR 97213

Affiliated Locations
Providence Portland Medical Center
Providence St. Vincent Medical Center
Providence Milwaukie Hospital
Providence Newberg Medical Center
Providence Willamette Falls Medical Center
Providence Seaside Hospital
Providence Hood River Memorial Hospital

Clinical Interests

  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genetics
  • Breast Cancer Genomics
  • Breast Cancer Screening
  • Breast Examination
  • Breast Lump
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Sexual Concerns
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoma In Situ Of Breast
  • Carcinoma Of Unknown Primary
  • Chemoradiation
  • Clinical Trials
  • Crizotinib
  • Ductal Carcinoma In Situ (Dcis)
  • Endocrine Complications Of Cancer Therapy
  • Erlotinib
  • Fibrocystic Breast Changes
  • Her2 Positive Breast Cancer
  • Hereditary Breast And Ovarian Cancer
  • Inflammatory Breast Cancer
  • Lobular Carcinoma In Situ (Lcis)
  • Male Breast Cancer
  • Metastatic Breast Cancer
  • Side Effects Of Cancer Treatment
  • Targeted Molecular Therapy
  • Unknown Primary Cancer